This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (17)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Men's Health  • Men's Health, Other  • Neurology  • Alzheimer Disease  • Women's Health  • Dementias  • Women's Health, Other  • Pathology & Laboratory Medicine  • Psychiatry, Other  • Alert me on articles by topic

Lisa L. Barnes, PhD; Robert S. Wilson, PhD; Julia L. Bienias, ScD; Julie A. Schneider, MD; Denis A. Evans, MD; David A. Bennett, MD

Arch Gen Psychiatry. 2005;62:685-691.

Context  Sex differences in risk of clinically diagnosed Alzheimer disease (AD) have been studied extensively, but little is known about the relation of the pathologic indices of AD to the clinical manifestations of the disease in men compared with women.

Objective  To test whether the relation of AD pathology to the clinical manifestations of the disease differs in men and women.

Design  Longitudinal, clinicopathologic cohort study.

Participants and Setting  Analyses were conducted on 141 older Catholic clergy members who underwent detailed annual clinical evaluations and brain autopsy at death. The number of neuritic plaques, diffuse plaques, and neurofibrillary tangles in a 1-mm² area sampled from 4 cortical regions was counted, and a global measure of AD pathology (range, 0-2.98 U) and specific measures of each pathology were derived.

Main Outcome Measures  Clinical diagnosis of probable AD and level of global cognitive function at the last evaluation before death.

Results  Women had more global AD pathology than did men (P = .04), due primarily to more neurofibrillary tangles (P = .02). At the last evaluation before death, 57 persons met clinical criteria for probable AD (34 [60%] of them women). In logistic regression models, sex was not related to odds of clinical AD (odds ratio [OR], 1.35; 95% confidence interval [CI], 0.56-3.25), but the relation of global AD pathology to clinical diagnosis differed for men and women. Each additional unit of AD pathology was associated with a nearly 3-fold increase in the odds of clinical AD in men (OR, 2.82; 95% CI, 1.03-7.65) compared with a more than 20-fold increase in the odds of clinical AD in women (OR, 22.67; 95% CI, 5.11-100.53). Results were unchanged after controlling for potential confounders or using level of cognition as the outcome.

Conclusion  These data suggest that AD pathology is more likely to be clinically expressed as dementia in women than in men.

Author Affiliations: Rush Alzheimer’s Disease Center (Drs Barnes, Wilson, Schneider, and Bennett), Departments of Neurological Sciences (Drs Barnes, Wilson, Schneider, Evans, and Bennett) and Psychology (Drs Barnes and Wilson), Rush Institute for Healthy Aging and Internal Medicine (Drs Bienias and Evans), and Department of Pathology (Dr Schneider), Rush University Medical Center, Chicago, Ill.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Occurrence of cognitive impairment and dementia in the community: A 9-year-long prospective study
Caracciolo et al.
Neurology 2008;70:1778-1785.
ABSTRACT | FULL TEXT  

Olfactory Ability in the Healthy Population: Reassessing Presbyosmia
Mackay-Sim et al.
Chem Senses 2006;31:763-771.
ABSTRACT | FULL TEXT  

Schooling mediates brain reserve in Alzheimer's disease: findings of fluoro-deoxy-glucose-positron emission tomography
Perneczky et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:1060-1063.
ABSTRACT | FULL TEXT  

Alzheimer Disease: Sex Matters
JWatch Psychiatry 2005;2005:10-10.
FULL TEXT  

Alzheimer Disease: Sex Matters
JWatch Women's Health 2005;2005:7-7.
FULL TEXT